A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers

European Journal of Vascular and Endovascular Surgery

Volumn 22, Issue 4, 2001, Pages 365-372

  Correction Arosio, E ^a   Ferrari, G ^b   Santoro, L ^b   Gianese, F ^b   Coccheri, S ^c   Zamboni, P ^d   Cisno, L ^d   Marchetti, F ^d   Anna, S ^e   Paroni, G ^f   Rossi, M ^f   Volpe, P ^f   Giovanni Rotondo, S ^g   Prisco, V ^g   Greco, R ^g   Severino, S ^h   Baccaglini, U ^h   Giraldi, E ^h   Persico, G ⁱ   Amato, B ⁱ   Rinaldi, O ^j   Lucchese, L ^a   Di Salvo, M ^k   Bisicchia, A ^k   Regina, G ^l   Fullone, M ^l   Lillo, A ^l   Barbarino, C ^m   Camilli, S ⁿ   Guarnera, G ⁿ   Furgiuele, S ⁿ   Apollonio, A ^o   Golisano, M ^o   Virgilio, V ^p   Carbone, G ^p   Croce, E ^q   Li Destri, A ^q   Di Falco, G ^q   Giulini, S M ^r   De Lucia, M ^r   Passarini, B ^c   Bandini, P ^c   Scorza, R ^s   Sgroi, G ^s   De Monti, M ^s   Paolo, S ^e   Lotti, T ^t   Comacchi, C ^t   Tsoureli, E ^t   more..

^a UNIVERSITY OF VERONA   (Italy)

^b Medical Department   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d Sezione di Chirurgia Generale   (Italy)

^e IRCCS Casa Sollievo della Sofferenza ^*  (Italy)

^f CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^g Centro di Angiologia Medica Os pedale di Mercato   (Italy)

^h UNIVERSITY HOSPITAL OF PADOVA   (Italy)

ⁱ FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^j Os pedale San Paolo   (Italy)

^k Ospedale Ferrarotto   (Italy)

^l Ospedale Consorziale Policlinico   (Italy)

^m Servizio di Medicina di Laboratorio   (Italy)

ⁿ LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^o Servizio di Angiologia Divisione di Me dicina Ospedale di Tarquinia   (Italy)

^p GARIBALDI HOSPITAL   (Italy)

^q Ospedale Civile di Vittoria   (Italy)

^r SPEDALI CIVILI   (Italy)

^s UNIVERSITY OF MILAN   (Italy)

^t UNIVERSITY OF FLORENCE   (Italy)

more..

Author keywords

Chronic venous insufficiency; Mesoglycan; Randomised clinical trial; Venous ulcers

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; MESOGLYCAN; PLACEBO; POLYSACCHARIDE SULFATE; PROSTANOID; TOPICAL AGENT;

ADULT; AGED; ANKLE; ARM; ARTICLE; BLEEDING; BLOOD PRESSURE MEASUREMENT; BRONCHOPNEUMONIA; CHRONIC DISEASE; CLINICAL OBSERVATION; CLINICAL TRIAL; COMPRESSION THERAPY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART PALPITATION; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METHODOLOGY; MULTICENTER STUDY; MUSCULOSKELETAL DISEASE; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RISK ASSESSMENT; STATISTICAL ANALYSIS; SYNCOPE; THROMBOPHLEBITIS; TREATMENT PLANNING; ULCER HEALING; ULTRASOUND; VEIN DISEASE; VEIN INSUFFICIENCY; WOUND CARE;

EID: 0034817233     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1478     Document Type: Article

References (32)

1. Chronic venous disorders of the leg: Epidemiology, outcomes, diagnosis and management. Summary of an evidence-based report of the VEINES task force
2. Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways
3. Insight into the mechanism of action of heparin cofactor II
4. Therapeutic uses of heparin beyond its traditional role as an anticoagulant
5. Effects of unfractionated heparin, dermatan sulfate and low molecular weight heparin on vessel wall permeability in rabbits
6. Effect of a single dose of mesoglycan on the human fibrinolytic system, and the profibrinolytic action of nine daily doses
7. Lack of correlation between in vitro and in vivo antithrombotic activity of heparin fractions and related compounds. Heparan sulfate as an antithrombotic agent in vivo
8. Antithrombotic properties of dermatan sulphate in a rat venous thrombosis model
9. Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer
10. Pericapillary fibrin cuffs in venous disease. A reappraisal
11. Pharmacokinetic aspects of tritium-labeled glycosaminoglycans (mesoglycan). Their absorption in rat and monkey and tissue distribution in rat
12. The absorption, clearance and metabolic fate of dermatan sulfate administered to man. Studies using a radioiodinated derivative
13. Valutazione strumentale degli effetti del mesoglicano in pazienti flebopatici
14. Studio controllato sull'efficacia del trattamento con mesoglicano in pazienti affetti da insufficienza venosa cronica e/o sindrome varicosa degli arti inferiori
15. SF-36 health survey manual and interpretation guide
16. Management of peripheral arterial disease (PAD)
17. Analogue chromatic continuous scale (ACCS): A new method for pain assessment
18. Questionario sullo stato di salute SF-36
19. Sample size determination for some common nonparametric statistics
20. Healing rates and cost efficacy of outpatient compression treatment for leg ulcers associated with venous insufficiency
21. Expected healing rates for chronic wounds
22. Perceived health in a randomised trial of treatment for chronic venous ulceration
23. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function
24. Heparan sulphate proteoglycan and wound healing in skin
25. Pharmacological actions of sulodexide
26. Antithrombotic activity of oral unfractionated heparin
27. Absorption and antithrombotic activity of unfractionated heparin after intraduodenal administration in rats
28. Treatment of venous leg ulcers with sulodexide
29. Oral pentoxifylline for treating venous leg ulcers
30. Efficacy of Daflon 500 mg in venous leg ulcer healing: A double-blind, randomized, controlled versus placebo trial in 107 patients
31. The beneficial augmentative effect of micronised purified flavonoid fraction (MPFF) on the healing of leg ulcers: An open, multicentre, controlled, randomised study